home / stock / skvi / skvi short
Short Information | Skinvisible (OTCMKTS:SKVI)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 84,675 |
Total Actual Volume | 162,155 |
Short Trends | |
---|---|
Cover Days | 8 |
Short Days | 12 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 4,234 |
Average Short Percentage | 56.74% |
Is there a SKVI Short Squeeze or Breakout about to happen?
See the SKVI Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-01-2024 | $0 | $0.7499 | $0 | $0 | 51 | 50 | 98.04% |
06-27-2024 | $0.7499 | $0.7499 | $0.7499 | $0.7499 | 2,009 | 9 | 0.45% |
06-21-2024 | $0.3 | $0.63 | $0.63 | $0.3 | 2,000 | 100 | 5% |
06-20-2024 | $0.2626 | $0.51 | $0.6 | $0.2626 | 2,400 | 2,100 | 87.5% |
06-17-2024 | $0 | $0.75 | $0 | $0 | 21 | 21 | 100% |
06-11-2024 | $0.6994 | $0.688 | $0.7125 | $0.55 | 8,308 | 1,800 | 21.67% |
06-10-2024 | $0.6994 | $0.6994 | $0.6994 | $0.6994 | 1,131 | 45 | 3.98% |
06-07-2024 | $0.5 | $0.4988 | $0.5099 | $0.4988 | 3,463 | 2,500 | 72.19% |
06-05-2024 | $0.44 | $0.42 | $0.442475 | $0.42 | 9,019 | 1,723 | 19.1% |
06-04-2024 | $0.3 | $0.5099 | $0.5099 | $0.3 | 16,360 | 4,600 | 28.12% |
06-03-2024 | $0.2044 | $0.2936 | $0.2936 | $0.1987 | 27,096 | 22,445 | 82.84% |
05-31-2024 | $0.1956 | $0.21 | $0.21 | $0.1701 | 10,068 | 2,011 | 19.97% |
05-29-2024 | $0.1041 | $0.1 | $0.1957 | $0.1 | 30,598 | 18,050 | 58.99% |
05-28-2024 | $0.123 | $0.123 | $0.123 | $0.101 | 5,080 | 995 | 19.59% |
05-14-2024 | $0 | $0.101 | $0 | $0 | 10 | 10 | 100% |
05-10-2024 | $0.101 | $0.101 | $0.101 | $0.101 | 1,000 | 1,000 | 100% |
05-01-2024 | $0.062 | $0.062 | $0.062 | $0.062 | 1,595 | 1,500 | 94.04% |
04-30-2024 | $0.1 | $0.1 | $0.1 | $0.1 | 14,084 | 9,054 | 64.29% |
04-22-2024 | $0.061 | $0.061 | $0.061 | $0.061 | 562 | 562 | 100% |
04-03-2024 | $0.09 | $0.07 | $0.09 | $0.07 | 27,300 | 16,100 | 58.97% |
News, Short Squeeze, Breakout and More Instantly...
Innovative Delivery System Shows Promise for GLP-1 Agonists, CB-1 Antagonists, and SGLT-2 Inhibitors LAS VEGAS, NV / ACCESSWIRE / June 24, 2024 / Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI ), an innovative topical / transdermal pharmaceutical research and development company, today anno...
TDCX Inc. American Depositary Shares each representing one Class A (TDCX) is expected to report for Q1 2024 nCino Inc. (NCNO) is expected to report $0 for Q1 2025 SK Telecom Co. Ltd. (SKM) is expected to report for Q1 2024 Redeia Corporacion S.A. ADR (RDEIY) is expected to report for ...
Administration of GLP-1 Receptor Agonists and CB-1 Receptor Antagonists Enhanced by Invisicare Topical / Transdermal Delivery System LAS VEGAS, NV / ACCESSWIRE / May 29, 2024 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB: SKVI ), an innovative pharmaceutical r...